speb/financial-data huggingface dataset:
Financial ratios for ASML.AS — quarterly report dated 2025-09-30
Total revenue: 8842352941.176472
Gross profit: 4565058823.529412
Operating income: 2904000000
Net income: 2499411764.7058825
Capital expenditures: 348117647.0588235
Operating cash flow: 657764705.882353
Depreciation & amortization: 323058823.5294118
Net tangible assets: 16293176470.588236
Owner earnings: 2474352941.1764708
Return on net tangible assets (%): 15.186436761690207
Capex to operating income (%): 11.98752228163993
Buffett classification: The Great
Stock price: 969.0705882352942
P/E ratio: 45.50586860983885
Shares outstanding: 385417665
Book value: 22345294117.647064
P/B ratio: 16.71479110417511
Market cap (USD): 373496923337.82355
Debt to equity: 0.1424013478295206
Current ratio: 1.308006803676482
Quick ratio: 0.6961544663431279
Effective tax rate (%): 17.774740734785755
COGS to revenue (%): 48.372804683342196
R&D to revenue (%): 14.751197445449705
SG&A to revenue (%): 4.034060670569452
Free cash flow (dilution-adjusted): 218823529.41176468
Buyback yield (%): 0.054240938180601564
Inventory turnover: 0.3090845717006155
Receivables turnover: 1.1251160144905843
Capitalized R&D asset: 2199372109.9744244
ROCI (R&D-adjusted, %): 9.543700417020537
Rosenberg metric: -0.26914841047603244
FCF margin (%): 2.4747205960617342
Revenue growth (%): -2.2842804581561773
Rule of 40 score: 0.19044013790555692
Financial ratios for ASML.AS — annual report dated 2025-12-31
Total revenue: 38432117647.05882
Gross profit: 20303529411.764706
Operating income: 13295764705.882353
Net income: 11305176470.588236
Capital expenditures: 1851294117.647059
Operating cash flow: 14892352941.176472
Depreciation & amortization: 1206941176.4705882
Net tangible assets: 17039411764.705883
Owner earnings: 10660823529.411766
Return on net tangible assets (%): 62.565678185521456
Capex to operating income (%): 13.923938627072754
Buffett classification: The Great
Stock price: 1080.1529411764707
P/E ratio: 36.82472586909172
Shares outstanding: 385417665
Book value: 23073176470.588234
P/B ratio: 18.043030397734576
Market cap (USD): 416310024431.1177
Debt to equity: 0.22388615249691518
Current ratio: 1.2617963311751201
Quick ratio: 0.7907549899233017
Effective tax rate (%): 17.65195816273748
Interest coverage ratio: 95.53169907016061
COGS to revenue (%): 47.17041200221628
R&D to revenue (%): 14.383802763007655
SG&A to revenue (%): 3.8503335139420773
Free cash flow (dilution-adjusted): 12735294117.647058
Buyback yield (%): 1.6814392133759954
Retained earnings: 20690941176.47059
Inventory turnover: 1.3482278004777195
Receivables turnover: 7.0719156582166125
Capitalized R&D asset: 9991177291.666668
ROCI (R&D-adjusted, %): 34.2305605556789
Rosenberg metric: 1.1616488684838897
FCF margin (%): 33.13711264781601
Revenue growth (%): 30.541568420708654
Rule of 40 score: 63.67868106852467
Financial ratios for ASML.AS — quarterly report dated 2025-12-31
Total revenue: 11433058823.529411
Gross profit: 5963058823.529412
Operating income: 4036588235.294118
Net income: 3340705882.352941
Capital expenditures: 526941176.47058827
Operating cash flow: 13423882352.941177
Depreciation & amortization: 300235294.11764705
Net tangible assets: 17039411764.705883
Owner earnings: 3114000000
Return on net tangible assets (%): 18.275278765491766
Capex to operating income (%): 13.05412258459386
Buffett classification: The Great
Stock price: 1080.1529411764707
P/E ratio: 36.04924279408484
Shares outstanding: 385417665
Book value: 23073176470.588234
P/B ratio: 18.043030397734576
Market cap (USD): 416310024431.1177
Debt to equity: 0.22388615249691518
Current ratio: 1.2617963311751201
Quick ratio: 0.7907549899233017
Effective tax rate (%): 17.97344798535863
COGS to revenue (%): 47.843714306294444
R&D to revenue (%): 12.989164548625762
SG&A to revenue (%): 3.8608369948858323
Free cash flow (dilution-adjusted): 12805058823.529411
Buyback yield (%): 0.480411203821713
Retained earnings: 20690941176.47059
Inventory turnover: 0.4068053161610947
Receivables turnover: 2.1038036066070616
Capitalized R&D asset: 2594672941.1764708
ROCI (R&D-adjusted, %): 12.981190095247078
Rosenberg metric: 1.071795796879228
FCF margin (%): 112.00028812216381
Revenue growth (%): 29.298829164449153
Rule of 40 score: 141.29911728661295
Financial ratios for AZO.TO — quarterly report dated 2026-02-28
Total revenue: 3119779562.0437956
Gross profit: 1637487591.2408757
Operating income: 509821897.81021893
Net income: 342233576.6423357
Capital expenditures: 245775912.40875912
Operating cash flow: 272575912.4087591
Depreciation & amortization: 113605839.41605839
Net tangible assets: -2344098540.145985
Owner earnings: 210063503.64963496
Return on net tangible assets (%): -8.961376838558701
Capex to operating income (%): 48.20819063763502
Buffett classification: The Good
Stock price: 16.802919708029197
P/E ratio: 34.35123992107566
Shares outstanding: 3625069391
Book value: -2123189781.0218983
Market cap (USD): 60911749913.0073
Debt to equity: -4.266847155326821
Current ratio: 0.8902220829469975
Quick ratio: 0.13587384513753023
Effective tax rate (%): 20.70034553852763
Interest coverage ratio: 6.515143883214401
COGS to revenue (%): 47.51271496348469
Free cash flow (dilution-adjusted): -18978.102189783007
Buyback yield (%): 0.3768956284388626
Retained earnings: -3205524817.518248
Inventory turnover: 0.2713426781944837
Receivables turnover: 6.120052808229378
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.640961941895862
FCF margin (%): -0.0006083154855130303
Revenue growth (%): -5.63749129091516
Rule of 40 score: -5.638099606400673
Financial ratios for AZO.TO — quarterly report dated 2026-04-30
Capital expenditures: 0
Net tangible assets: -2253428467.1532845
Buffett classification: The Gruesome
Stock price: 16.474452554744524
Shares outstanding: 3625069391
Book value: -2032519708.0291977
Market cap (USD): 59721033689.68613
Debt to equity: -4.536159137987007
Current ratio: 0.8903129379223149
Quick ratio: 0.13706727433414384
Buyback yield (%): 0
Retained earnings: -2737283211.678832
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BEM.L — annual report dated 2021-12-31
Total revenue: 0
Operating income: -1941162.1621621621
Net income: -1825917.5675675676
Capital expenditures: 82990.54054054055
Operating cash flow: -1824033.783783784
Depreciation & amortization: 57324.32432432433
Net tangible assets: 19150527.027027026
Owner earnings: -1851583.783783784
Return on net tangible assets (%): -9.66857873504293
Buffett classification: The Gruesome
Stock price: 0.0777027027027027
Shares outstanding: 64703707
Book value: 19589768.91891892
P/B ratio: 0.25664687161921046
Market cap (USD): 5027652.908783783
Debt to equity: 0.0005167479522025735
Current ratio: 8.698669718421261
Quick ratio: 8.698669718421261
Interest coverage ratio: -5611.171875
Free cash flow (dilution-adjusted): -2966466.2162162163
Buyback yield (%): 0
Retained earnings: -24960371.621621624
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.909061052208099
Rule of 40 score: 0
Financial ratios for BEM.L — annual report dated 2022-12-31
Total revenue: 0
Operating income: -2074439.7590361447
Net income: -2347540.9638554216
Capital expenditures: 41442.1686746988
Operating cash flow: -1854883.1325301207
Depreciation & amortization: 62068.674698795185
Net tangible assets: 14570887.951807229
Owner earnings: -2326914.457831325
Return on net tangible assets (%): -15.969613283195397
Buffett classification: The Gruesome
Stock price: 0.02265060240963855
Shares outstanding: 64703707
Book value: 15256107.228915662
P/B ratio: 0.09606500004856833
Market cap (USD): 1465577.941686747
Debt to equity: 0.147310075862173
Current ratio: 0.8044186605771481
Quick ratio: 0.8044186605771481
Interest coverage ratio: -5.6487897219871
Free cash flow (dilution-adjusted): -4037543.373493976
Buyback yield (%): 0
Retained earnings: -24486040.963855423
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.588277140132837
Rule of 40 score: 0
Financial ratios for BEM.L — annual report dated 2023-12-31
Total revenue: 0
Operating income: -3043687.3417721516
Net income: -3625264.5569620254
Capital expenditures: 50851.898734177215
Operating cash flow: -2746359.493670886
Depreciation & amortization: 92093.67088607594
Net tangible assets: 19028300
Owner earnings: -3584022.7848101263
Return on net tangible assets (%): -18.83522324542984
Buffett classification: The Gruesome
Stock price: 0.008227848101265823
Shares outstanding: 64703707
Book value: 19775037.97468354
P/B ratio: 0.026921428594289698
Market cap (USD): 532372.2727848102
Debt to equity: 0.002408611291053547
Current ratio: 2.3180035814719107
Quick ratio: 2.3180035814719107
Interest coverage ratio: -12.160956687099189
Free cash flow (dilution-adjusted): -6210048.101265823
Buyback yield (%): 0
Retained earnings: -29412043.03797468
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.376746149743054
Rule of 40 score: 0
Financial ratios for BEM.L — quarterly report dated 2024-09-30
Total revenue: 0
Operating income: -544806.6666666666
Net income: -543160
Capital expenditures: 0
Net tangible assets: 22595310.666666668
Owner earnings: -543160
Return on net tangible assets (%): -2.403861615416013
Buffett classification: The Gruesome
Stock price: 0.0033333333333333335
Shares outstanding: 64703707
Book value: 22926894.666666668
P/B ratio: 0.009407249715632372
Market cap (USD): 215679.02333333335
Debt to equity: 0.0022055029287001565
Current ratio: 3.733280031394353
Quick ratio: 3.733280031394353
Interest coverage ratio: -646.5268987341772
Buyback yield (%): 0
Retained earnings: -32851714.666666668
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.3741198767122893
Rule of 40 score: 0
Financial ratios for BEM.L — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -410771.25
Net income: -505640
Capital expenditures: 0
Net tangible assets: 20212146.25
Owner earnings: -505640
Return on net tangible assets (%): -2.5016640674663635
Buffett classification: The Gruesome
Stock price: 0.001875
Shares outstanding: 64703707
Book value: 20839277.5
P/B ratio: 0.005821672590376513
Market cap (USD): 121319.450625
Debt to equity: 0.0018440538545542186
Current ratio: 2.030554920005824
Quick ratio: 2.030554920005824
Interest coverage ratio: -623.561669829222
Buyback yield (%): 0
Retained earnings: -30955067.5
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.969956067336641
Rule of 40 score: 0
Financial ratios for BEM.L — annual report dated 2024-12-31
Total revenue: 0
Operating income: -1923043.75
Net income: -2214156.25
Capital expenditures: 7635
Operating cash flow: -1490353.75
Depreciation & amortization: 79165
Net tangible assets: 20212146.25
Owner earnings: -2142626.25
Return on net tangible assets (%): -10.6006864560462
Buffett classification: The Gruesome
Stock price: 0.001875
Shares outstanding: 64703707
Book value: 20839277.5
P/B ratio: 0.005821672590376513
Market cap (USD): 121319.450625
Debt to equity: 0.0012432652715527205
Current ratio: 2.030554920005824
Quick ratio: 2.030554920005824
Interest coverage ratio: -25.177320633673737
Free cash flow (dilution-adjusted): -4737665
Buyback yield (%): 0
Retained earnings: -30955067.5
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.222436339121364
Rule of 40 score: 0
Financial ratios for BEM.L — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -538059.7402597403
Net income: -584774.025974026
Capital expenditures: 0
Net tangible assets: 21379437.66233766
Owner earnings: -584774.025974026
Return on net tangible assets (%): -2.735217058604739
Buffett classification: The Gruesome
Stock price: 0.0023376623376623377
Shares outstanding: 64703707
Book value: 22192428.57142857
P/B ratio: 0.006815631667990194
Market cap (USD): 151255.41896103896
Debt to equity: 0.03873516005517267
Current ratio: 0.7054003710547548
Quick ratio: 0.7054003710547548
Interest coverage ratio: -91.62007961079168
Buyback yield (%): 0
Retained earnings: -32745883.116883118
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.421595762321392
Rule of 40 score: 0
Financial ratios for BEM.L — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -829502.7397260275
Net income: -873321.9178082192
Capital expenditures: 0
Net tangible assets: 24258742.465753425
Owner earnings: -873321.9178082192
Return on net tangible assets (%): -3.600029634846514
Buffett classification: The Gruesome
Stock price: 0.0015068493150684932
Shares outstanding: 64703707
Book value: 25187189.04109589
P/B ratio: 0.0038709653711758666
Market cap (USD): 97498.73657534247
Debt to equity: 0.002195778153799431
Current ratio: 2.368451345307463
Quick ratio: 2.368451345307463
Interest coverage ratio: -12.33172450309547
Buyback yield (%): 0
Retained earnings: -35413500
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.290380953928298
Rule of 40 score: 0
Financial ratios for BEM.L — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -459741.8918918919
Net income: -458931.08108108107
Capital expenditures: 0
Net tangible assets: 24071004.054054055
Owner earnings: -458931.08108108107
Return on net tangible assets (%): -1.9065722395729794
Buffett classification: The Gruesome
Stock price: 0.0014864864864864867
Shares outstanding: 64703707
Book value: 25025878.378378376
P/B ratio: 0.0038432691403223157
Market cap (USD): 96181.18608108109
Debt to equity: 0.0018049424514624054
Current ratio: 1.227122969132751
Quick ratio: 1.227122969132751
Interest coverage ratio: -577.6044142614601
Buyback yield (%): 0
Retained earnings: -35393870.27027027
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.8358069034766147
Rule of 40 score: 0
Financial ratios for BEM.L — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -238700
Net income: -432659.45945945947
Capital expenditures: 0
Net tangible assets: 24062966.216216218
Owner earnings: -432659.45945945947
Return on net tangible assets (%): -1.7980304488308965
Buffett classification: The Gruesome
Stock price: 0.0014864864864864867
Shares outstanding: 64703707
Book value: 25071114.864864863
P/B ratio: 0.0038363346265016416
Market cap (USD): 96181.18608108109
Debt to equity: 0.01843442639518667
Current ratio: 4.692456626507432
Quick ratio: 4.692456626507432
Interest coverage ratio: -28.343709884467266
Buyback yield (%): 0
Retained earnings: -35826529.72972973
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.9516155343513178
Rule of 40 score: 0
Financial ratios for BEM.L — annual report dated 2025-12-31
Total revenue: 0
Operating income: -2112564.864864865
Net income: -2361591.891891892
Capital expenditures: 5124.324324324324
Operating cash flow: -1764302.7027027027
Depreciation & amortization: 92963.51351351352
Net tangible assets: 24062966.216216218
Owner earnings: -2273752.702702703
Return on net tangible assets (%): -9.449178801449689
Buffett classification: The Gruesome
Stock price: 0.0014864864864864867
Shares outstanding: 64703707
Book value: 25071114.864864863
P/B ratio: 0.0038363346265016416
Market cap (USD): 96181.18608108109
Debt to equity: 0.01843442639518667
Current ratio: 4.692456626507432
Quick ratio: 4.692456626507432
Interest coverage ratio: -25.726524701313235
Free cash flow (dilution-adjusted): -4163078.378378378
Buyback yield (%): 0
Retained earnings: -35826529.72972973
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.422076006410549
Rule of 40 score: 0
Financial ratios for BLDR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 85.71
Shares outstanding: 107559876
Market cap (USD): 9218956971.96
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLDR — annual report dated 2022-12-31
Total revenue: 22726418000
Gross profit: 7744379000
Operating income: 3770206000
Net income: 2749369000
Capital expenditures: 329465000
Operating cash flow: 3599231000
Depreciation & amortization: 497140000
Net tangible assets: -45232000
Owner earnings: 2917044000
Return on net tangible assets (%): -6449.071453837991
Capex to operating income (%): 8.738647172064338
Buffett classification: The Great
Stock price: 64.88
P/E ratio: 2.5382132245180618
Shares outstanding: 107559876
Book value: 4962566000
P/B ratio: 1.406225076881597
Market cap (USD): 6978484754.879999
Debt to equity: 0.7031479279066515
Current ratio: 1.8980284667884755
Quick ratio: 1.1240908432318797
Effective tax rate (%): 23.0263844922201
Interest coverage ratio: 19.005640888628996
COGS to revenue (%): 65.92345084913953
SG&A to revenue (%): 17.48701885180498
Free cash flow (dilution-adjusted): 3227742000
Buyback yield (%): 37.162637608206616
Retained earnings: 703510000
Inventory turnover: 10.504894839138519
Receivables turnover: 12.173964607979944
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 43.07634688206557
FCF margin (%): 14.20259893134061
Rule of 40 score: 14.20259893134061
Financial ratios for BLDR — annual report dated 2023-12-31
Total revenue: 17097330000
Gross profit: 6012334000
Operating income: 2176319000
Net income: 1540555000
Capital expenditures: 429620000
Operating cash flow: 2306872000
Depreciation & amortization: 558275000
Net tangible assets: -122378000
Owner earnings: 1669210000
Return on net tangible assets (%): -1363.978819722499
Capex to operating income (%): 19.74067220844003
Buffett classification: The Great
Stock price: 166.94
P/E ratio: 11.655569388590475
Shares outstanding: 107559876
Book value: 4732351000
P/B ratio: 3.794318236208599
Market cap (USD): 17956045699.44
Debt to equity: 0.7846751012340378
Current ratio: 1.77131182862635
Quick ratio: 1.112172292382302
Effective tax rate (%): 22.359041711436927
Interest coverage ratio: 11.328209666085417
COGS to revenue (%): 64.83466131846318
SG&A to revenue (%): 22.436339475228003
Free cash flow (dilution-adjusted): 1782015000
Buyback yield (%): 10.088618787913289
Retained earnings: 460184000
Inventory turnover: 9.024922146279508
Receivables turnover: 9.032328105387277
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.200500462308135
FCF margin (%): 10.422767765493209
Revenue growth (%): -24.768918709494827
Rule of 40 score: -14.346150944001618
Financial ratios for BLDR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 142.93
Shares outstanding: 107559876
Market cap (USD): 15373533076.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLDR — annual report dated 2024-12-31
Total revenue: 16400492000
Gross profit: 5383044000
Operating income: 1595249000
Net income: 1077898000
Capital expenditures: 366575000
Operating cash flow: 1872692000
Depreciation & amortization: 561929000
Net tangible assets: -485668000
Owner earnings: 1273252000
Return on net tangible assets (%): -262.165100438983
Capex to operating income (%): 22.97917127670978
Buffett classification: The Great
Stock price: 142.93
P/E ratio: 14.262511922909217
Shares outstanding: 107559876
Book value: 4296470000
P/B ratio: 3.578177684629475
Market cap (USD): 15373533076.68
Debt to equity: 1.0084615975440303
Current ratio: 1.7674457990767893
Quick ratio: 1.0852923237583807
Effective tax rate (%): 22.3150573863534
Interest coverage ratio: 7.679656659798579
COGS to revenue (%): 67.17754564924027
SG&A to revenue (%): 23.095618107066542
Free cash flow (dilution-adjusted): 1429012000
Buyback yield (%): 9.868460245493763
Retained earnings: 24065000
Inventory turnover: 9.087491906382102
Receivables turnover: 9.888249253580163
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.115868954701497
FCF margin (%): 8.713226408085806
Revenue growth (%): -4.075712406557047
Rule of 40 score: 4.637514001528759
Financial ratios for BLDR — quarterly report dated 2025-03-31
Total revenue: 3657496000
Gross profit: 1115241000
Operating income: 184441000
Net income: 96304000
Capital expenditures: 87261000
Operating cash flow: 132328000
Depreciation & amortization: 145031000
Net tangible assets: -913156000
Owner earnings: 154074000
Return on net tangible assets (%): -16.872692070139166
Capex to operating income (%): 47.31106424276598
Buffett classification: The Good
Stock price: 124.94
P/E ratio: 34.88570284578003
Shares outstanding: 107559876
Book value: 4374160000
P/B ratio: 3.0722540801982547
Market cap (USD): 13438530907.44
Debt to equity: 1.1680473508056404
Current ratio: 1.8209742563792843
Quick ratio: 1.0721860539474737
Effective tax rate (%): 19.44391002852387
Interest coverage ratio: 2.8422763977069594
COGS to revenue (%): 69.50807328292362
SG&A to revenue (%): 25.4491050707916
Free cash flow (dilution-adjusted): 18116000
Buyback yield (%): 0.09187760243319681
Retained earnings: 107620000
Inventory turnover: 1.8846749484212797
Receivables turnover: 2.172251571654684
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9120667614954303
FCF margin (%): 0.49531154647879316
Rule of 40 score: 0.49531154647879316
Financial ratios for BLDR — quarterly report dated 2025-06-30
Total revenue: 4234064000
Gross profit: 1299041000
Operating income: 311287000
Net income: 185031000
Capital expenditures: 86020000
Operating cash flow: 341040000
Depreciation & amortization: 147524000
Net tangible assets: -1073172000
Owner earnings: 246535000
Return on net tangible assets (%): -22.97255239607444
Capex to operating income (%): 27.63366282562394
Buffett classification: The Good
Stock price: 116.69
P/E ratio: 16.95818799341732
Shares outstanding: 107559876
Book value: 4178092000
P/B ratio: 3.0040415410766443
Market cap (USD): 12551161930.44
Debt to equity: 1.2719947286943418
Current ratio: 1.791977242290139
Quick ratio: 1.0784337558887864
Effective tax rate (%): 22.67790504766004
Interest coverage ratio: 4.324151247430128
COGS to revenue (%): 69.31928756863383
SG&A to revenue (%): 23.328745148868794
Free cash flow (dilution-adjusted): 236141000
Buyback yield (%): 3.199783432209459
Retained earnings: 0
Inventory turnover: 2.2420347279673116
Receivables turnover: 2.4048300343623095
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.232496954285413
FCF margin (%): 5.57717124729338
Revenue growth (%): 15.76400903787728
Rule of 40 score: 21.34118028517066
Financial ratios for BLDR — quarterly report dated 2025-09-30
Total revenue: 3941190000
Gross profit: 1199483000
Operating income: 228768000
Net income: 122384000
Capital expenditures: 82842000
Operating cash flow: 547724000
Depreciation & amortization: 147535000
Net tangible assets: -876155000
Owner earnings: 187077000
Return on net tangible assets (%): -21.35204387351553
Capex to operating income (%): 36.212232480067144
Buffett classification: The Good
Stock price: 121.25
P/E ratio: 32.3037433586232
Shares outstanding: 107559876
Book value: 4316189000
P/B ratio: 3.0215625323636197
Market cap (USD): 13041634965
Debt to equity: 1.1772322759730864
Current ratio: 1.7864723627459376
Quick ratio: 1.1488698063283909
Effective tax rate (%): 23.27502977869726
Interest coverage ratio: 3.3031274365416268
COGS to revenue (%): 69.56546119319292
SG&A to revenue (%): 24.62999753881442
Free cash flow (dilution-adjusted): 445504000
Buyback yield (%): 7.667750268150524e-06
Retained earnings: 122384000
Inventory turnover: 2.3305333343533694
Receivables turnover: 2.3150175189213162
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3865298267719095
FCF margin (%): 11.303794031751831
Revenue growth (%): -6.917089585797474
Rule of 40 score: 4.386704445954357
Financial ratios for BLDR — annual report dated 2025-12-31
Total revenue: 15190638000
Gross profit: 4615777000
Operating income: 786276000
Net income: 435199000
Capital expenditures: 341852000
Operating cash flow: 1215886000
Depreciation & amortization: 591432000
Net tangible assets: -968919000
Owner earnings: 684779000
Return on net tangible assets (%): -70.67453522946707
Capex to operating income (%): 43.47735400800737
Buffett classification: The Good
Stock price: 102.89
P/E ratio: 25.429368269780028
Shares outstanding: 107559876
Book value: 4352251000
P/B ratio: 2.542784329681353
Market cap (USD): 11066835641.64
Debt to equity: 1.1718696830674518
Current ratio: 1.8586620070212154
Quick ratio: 1.1635985094044792
Effective tax rate (%): 15.06356585516275
Interest coverage ratio: 2.8707310127275516
COGS to revenue (%): 69.61433087932186
SG&A to revenue (%): 25.209612657480218
Free cash flow (dilution-adjusted): 799772000
Buyback yield (%): 3.7405272239016947
Retained earnings: 153866000
Inventory turnover: 9.660195088262915
Receivables turnover: 9.967381326544338
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.137322202155136
FCF margin (%): 5.264900657892051
Revenue growth (%): -7.376937228468512
Rule of 40 score: -2.1120365705764614
Financial ratios for BLDR — quarterly report dated 2025-12-31
Total revenue: 3357888000
Gross profit: 1002012000
Operating income: 61780000
Net income: 31480000
Capital expenditures: 85729000
Operating cash flow: 194794000
Depreciation & amortization: 151342000
Net tangible assets: -968919000
Owner earnings: 97093000
Return on net tangible assets (%): -10.020755088918682
Capex to operating income (%): 138.76497248300421
Buffett classification: The Gruesome
Stock price: 102.89
P/E ratio: 25.429368269780028
Shares outstanding: 107559876
Book value: 4352251000
P/B ratio: 2.542784329681353
Market cap (USD): 11066835641.64
Debt to equity: 1.1718696830674518
Current ratio: 1.8586620070212154
Quick ratio: 1.1635985094044792
Interest coverage ratio: 0.9118146262268467
COGS to revenue (%): 70.15945737320601
SG&A to revenue (%): 28.000695675376903
Free cash flow (dilution-adjusted): 100011000
Buyback yield (%): 0
Retained earnings: 153866000
Inventory turnover: 2.1521059958855706
Receivables turnover: 2.2032879822313793
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6393731535098927
FCF margin (%): 2.9783899879924522
Revenue growth (%): -14.800149193517695
Rule of 40 score: -11.821759205525243
Financial ratios for BYS.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1205.7252747252746
Shares outstanding: 1821355
Market cap (USD): 2196053757.7472525
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BYS.SW — annual report dated 2022-12-31
Total revenue: 1104239130.4347825
Gross profit: 497717391.3043478
Operating income: 52608695.652173914
Net income: 39782608.69565217
Capital expenditures: 19456521.739130434
Operating cash flow: -17934782.608695652
Depreciation & amortization: 23586956.52173913
Net tangible assets: 775217391.3043478
Owner earnings: 43913043.47826086
Return on net tangible assets (%): 5.664610207515422
Capex to operating income (%): 36.98347107438016
Buffett classification: The Good
Stock price: 640.4782608695652
P/E ratio: 29.32282022404372
Shares outstanding: 1821355
Book value: 787173913.0434783
P/B ratio: 1.481932090858879
Market cap (USD): 1166538282.826087
Debt to equity: 0
Current ratio: 2.2975492807671816
Quick ratio: 1.531166755460842
Effective tax rate (%): 19.60352422907489
Interest coverage ratio: 8.066666666666666
COGS to revenue (%): 54.9266660104341
SG&A to revenue (%): 3.583029825770253
Free cash flow (dilution-adjusted): -44239130.43478261
Buyback yield (%): 0.09317795547230909
Retained earnings: 819239130.4347826
Inventory turnover: 1.9395203336809177
Receivables turnover: 6.075956937799043
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.309477251988007
FCF margin (%): -4.006299832660695
Rule of 40 score: -4.006299832660695
Financial ratios for BYS.SW — annual report dated 2023-12-31
Total revenue: 1107261904.7619047
Gross profit: 528214285.71428573
Operating income: 64761904.76190476
Net income: 49880952.38095238
Capital expenditures: 14285714.285714285
Operating cash flow: 63809523.80952381
Depreciation & amortization: 25000000
Net tangible assets: 856904761.9047619
Owner earnings: 60595238.095238104
Return on net tangible assets (%): 7.071408724645736
Capex to operating income (%): 22.058823529411764
Buffett classification: The Great
Stock price: 531.1190476190476
P/E ratio: 19.393301186157515
Shares outstanding: 1821355
Book value: 869761904.7619048
P/B ratio: 1.1122082120175196
Market cap (USD): 967356332.9761904
Debt to equity: 0
Current ratio: 2.939405634890004
Quick ratio: 2.021227325357005
Effective tax rate (%): 23.77495462794918
Interest coverage ratio: 7.7714285714285705
COGS to revenue (%): 52.29545210192453
SG&A to revenue (%): 3.0641866465971406
Free cash flow (dilution-adjusted): 39404761.90476191
Buyback yield (%): 0.061532454478979044
Retained earnings: 904285714.2857143
Inventory turnover: 2.0445565363598153
Receivables turnover: 7.915744680851063
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.11111111111111
FCF margin (%): 3.558757122890013
Revenue growth (%): 0.273742728708774
Rule of 40 score: 3.832499851598787
Financial ratios for BYS.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 699222222.2222222
Buffett classification: The Gruesome
Stock price: 332
Shares outstanding: 1821355
Book value: 708111111.1111112
P/B ratio: 0.8539477075160834
Market cap (USD): 604689860
Debt to equity: 0
Current ratio: 2.496249062265566
Quick ratio: 1.743060765191298
Buyback yield (%): 0
Retained earnings: 740444444.4444444
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BYS.SW — annual report dated 2024-12-31
Total revenue: 720333333.3333334
Gross profit: 336111111.1111111
Operating income: -93444444.44444445
Net income: -75111111.1111111
Capital expenditures: 11000000
Operating cash flow: 15555555.555555556
Depreciation & amortization: 28777777.777777776
Net tangible assets: 699222222.2222222
Owner earnings: -57333333.33333333
Return on net tangible assets (%): -8.199586842523438
Buffett classification: The Gruesome
Stock price: 332
Shares outstanding: 1821355
Book value: 708111111.1111112
P/B ratio: 0.8539477075160834
Market cap (USD): 604689860
Debt to equity: 0
Current ratio: 2.496249062265566
Quick ratio: 1.743060765191298
Interest coverage ratio: -10.256097560975611
COGS to revenue (%): 53.33950331636588
SG&A to revenue (%): 4.025913928736696
Free cash flow (dilution-adjusted): -1555555.5555555555
Buyback yield (%): 0.23887360116216344
Retained earnings: 740444444.4444444
Inventory turnover: 1.7221115537848606
Receivables turnover: 6.867584745762713
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.849503437738733
FCF margin (%): -0.2159494061391331
Revenue growth (%): -34.94462960971938
Rule of 40 score: -35.16057901585851
Financial ratios for BYS.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 760375000
Buffett classification: The Gruesome
Stock price: 472.06249999999994
Shares outstanding: 1821355
Book value: 769250000
P/B ratio: 1.1177034705069873
Market cap (USD): 859793394.6874999
Debt to equity: 0
Current ratio: 2.8017699115044246
Quick ratio: 1.9778761061946903
Buyback yield (%): 0
Retained earnings: 805125000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGNT — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.85
Shares outstanding: 73705907
Market cap (USD): 799709090.9499999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGNT — annual report dated 2023-01-31
Total revenue: 90191329.47976878
Gross profit: 55528034.682080925
Operating income: -29862138.728323698
Net income: -31777745.664739884
Capital expenditures: 2391329.479768786
Operating cash flow: -10689884.393063584
Depreciation & amortization: 5216763.005780347
Net tangible assets: 16556936.416184971
Owner earnings: -28952312.138728324
Return on net tangible assets (%): -174.86515265243423
Buffett classification: The Gruesome
Stock price: 3.79
Shares outstanding: 73705907
Book value: 60628323.69942196
P/B ratio: 4.607506368061819
Market cap (USD): 279345387.53000003
Debt to equity: 0.08090611801271846
Current ratio: 1.2985102344007924
Quick ratio: 1.1681918537471114
Interest coverage ratio: -64.69818409517846
COGS to revenue (%): 38.433067787811396
R&D to revenue (%): 44.96670533419641
SG&A to revenue (%): 49.4603636456858
Free cash flow (dilution-adjusted): -21362716.763005782
Buyback yield (%): 0
Retained earnings: -37289595.37572254
Inventory turnover: 4.747456754938051
Receivables turnover: 2.266163174902872
Capitalized R&D asset: 40556069.36416185
ROCI (R&D-adjusted, %): -2.50898909670916
FCF margin (%): -23.68599829521057
Rule of 40 score: -23.68599829521057
Financial ratios for CGNT — annual report dated 2024-01-31
Total revenue: 85629508.19672132
Gross profit: 58853551.9125683
Operating income: -4932786.8852459015
Net income: -3181693.989071038
Capital expenditures: 1922131.1475409835
Operating cash flow: 9442896.174863387
Depreciation & amortization: 3774863.387978142
Net tangible assets: 17126775.95628415
Owner earnings: -1328961.7486338795
Return on net tangible assets (%): -7.759555867526002
Buffett classification: The Gruesome
Stock price: 7.08
Shares outstanding: 73705907
Book value: 58670218.57923497
P/B ratio: 8.894424363789451
Market cap (USD): 521837821.56
Debt to equity: 0.15536969166360085
Current ratio: 1.3912173762384035
Quick ratio: 1.2621451485034152
Interest coverage ratio: -1128.3750000000002
COGS to revenue (%): 31.26954346466541
R&D to revenue (%): 34.231535015507134
SG&A to revenue (%): 40.13477811387219
Free cash flow (dilution-adjusted): 3640710.3825136614
Buyback yield (%): 0
Retained earnings: -39506010.92896175
Inventory turnover: 3.986332574031891
Receivables turnover: 2.4800898961762474
Capitalized R&D asset: 56484861.55595565
ROCI (R&D-adjusted, %): 0.8169547861820756
Rosenberg metric: 0.08199801614468176
FCF margin (%): 4.2517006802721085
Revenue growth (%): -5.057937730112682
Rule of 40 score: -0.8062370498405738
Financial ratios for CGNT — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.49
Shares outstanding: 73705907
Market cap (USD): 478351336.43
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGNT — quarterly report dated 2025-01-31
Total revenue: 26398044.69273743
Gross profit: 18725977.653631285
Operating income: 194692.7374301676
Net income: -60335.195530726254
Capital expenditures: 1025977.653631285
Operating cash flow: 5220670.391061452
Depreciation & amortization: 912849.1620111732
Net tangible assets: 17857821.22905028
Owner earnings: -173463.68715083797
Return on net tangible assets (%): -0.9713597472274795
Capex to operating income (%): 526.9727403156385
Buffett classification: The Gruesome
Stock price: 9.31
Shares outstanding: 73705907
Book value: 60643296.08938548
P/B ratio: 11.31538089813867
Market cap (USD): 686201994.1700001
Debt to equity: 0.16365503931313707
Current ratio: 1.304484388747316
Quick ratio: 1.2179238789028133
Interest coverage ratio: 17
COGS to revenue (%): 29.063012539019102
R&D to revenue (%): 29.70953917782128
SG&A to revenue (%): 40.44759536532459
Free cash flow (dilution-adjusted): 2559776.5363128493
Buyback yield (%): 0
Retained earnings: -43755027.93296089
Inventory turnover: 1.446492521592585
Receivables turnover: 0.7695721568052637
Capitalized R&D asset: 7842737.430167598
ROCI (R&D-adjusted, %): 6.333676958008194
FCF margin (%): 9.696841436961009
Rule of 40 score: 9.696841436961009
Financial ratios for CGNT — annual report dated 2025-01-31
Total revenue: 97941899.44134077
Gross profit: 68972625.69832402
Operating income: -1431843.5754189943
Net income: -2020670.3910614525
Capital expenditures: 2957262.5698324023
Operating cash flow: 13067597.765363129
Depreciation & amortization: 3813407.8212290504
Net tangible assets: 17857821.22905028
Owner earnings: -1164525.1396648043
Return on net tangible assets (%): -6.521093053448249
Buffett classification: The Gruesome
Stock price: 9.31
Shares outstanding: 73705907
Book value: 60643296.08938548
P/B ratio: 11.31538089813867
Market cap (USD): 686201994.1700001
Debt to equity: 0.16365503931313707
Current ratio: 1.304484388747316
Quick ratio: 1.2179238789028133
Interest coverage ratio: -51.26
COGS to revenue (%): 29.57801911976089
R&D to revenue (%): 30.879668712496294
SG&A to revenue (%): 40.93066234684798
Free cash flow (dilution-adjusted): 4068435.754189944
Buyback yield (%): 0.21476810462236437
Retained earnings: -43755027.93296089
Inventory turnover: 5.461870655150622
Receivables turnover: 2.855262943600267
Capitalized R&D asset: 63266874.67330374
ROCI (R&D-adjusted, %): -3.231892069104356
Rosenberg metric: 0.3452160179699109
FCF margin (%): 4.153927764721988
Revenue growth (%): 14.37867798602035
Rule of 40 score: 18.532605750742338
Financial ratios for CGNT — quarterly report dated 2025-04-30
Total revenue: 26394475.138121545
Gross profit: 18824861.87845304
Operating income: 594751.3812154696
Net income: 39226.51933701657
Capital expenditures: 1090607.7348066298
Operating cash flow: 472375.6906077348
Depreciation & amortization: 769889.5027624309
Net tangible assets: 19028729.281767957
Owner earnings: -281491.7127071823
Return on net tangible assets (%): -1.4792985308634803
Capex to operating income (%): 183.37203901532746
Buffett classification: The Gruesome
Stock price: 9.8
P/E ratio: 4603.5048534014095
Shares outstanding: 73705907
Book value: 59611325.96685082
P/B ratio: 12.117125007446955
Market cap (USD): 722317888.6
Debt to equity: 0.14540786772508843
Current ratio: 1.3348097568450188
Quick ratio: 1.2477805763318937
Effective tax rate (%): 96.68146763262445
Interest coverage ratio: 40.62264150943396
COGS to revenue (%): 28.678779252312975
R&D to revenue (%): 30.45380332398376
SG&A to revenue (%): 38.61409971951271
Free cash flow (dilution-adjusted): -2108287.2928176792
Buyback yield (%): 0.3423218464787246
Retained earnings: -43542541.436464086
Inventory turnover: 1.50767537826685
Receivables turnover: 0.7957823899790119
Capitalized R&D asset: 13292755.625173617
ROCI (R&D-adjusted, %): 3.6544244039691303
Rosenberg metric: 0.012608381410474004
FCF margin (%): -7.987608322518525
Revenue growth (%): -0.013522041717230166
Rule of 40 score: -8.001130364235754
Financial ratios for CGNT — quarterly report dated 2025-07-31
Total revenue: 28850000
Gross profit: 20639349.112426035
Operating income: 812130.1775147929
Net income: 808875.7396449704
Capital expenditures: 606804.7337278107
Operating cash flow: -1869526.627218935
Depreciation & amortization: 897928.9940828403
Net tangible assets: 20995266.27218935
Owner earnings: 1100000
Return on net tangible assets (%): 5.239276252747873
Capex to operating income (%): 74.7176684881603
Buffett classification: The Good
Stock price: 9.26
P/E ratio: 866.3940528686846
Shares outstanding: 73705907
Book value: 66588165.68047337
P/B ratio: 10.249819796735208
Market cap (USD): 682516698.8199999
Debt to equity: 0.13794497662928537
Current ratio: 1.3425601413806454
Quick ratio: 1.2605812094796516
Effective tax rate (%): -96.97406340057637
Interest coverage ratio: 45
COGS to revenue (%): 28.459795104242513
R&D to revenue (%): 29.951903848717603
SG&A to revenue (%): 38.69432793576241
Free cash flow (dilution-adjusted): -4128698.224852071
Buyback yield (%): 0.2495983319973341
Retained earnings: -46199704.142011836
Inventory turnover: 1.6805135036938355
Receivables turnover: 0.7658289484017906
Capitalized R&D asset: 16614769.048774427
ROCI (R&D-adjusted, %): 1.2618299008646983
Rosenberg metric: 0.2257352322146624
FCF margin (%): -14.310912391168356
Revenue growth (%): 9.303177460543399
Rule of 40 score: -5.007734930624958
Financial ratios for CGNT — quarterly report dated 2025-10-31
Total revenue: 30996307.692307692
Gross profit: 22475692.307692308
Operating income: 985538.4615384615
Net income: -1040307.6923076923
Capital expenditures: 532615.3846153846
Operating cash flow: 7683692.307692308
Depreciation & amortization: 968000
Net tangible assets: 22193846.153846152
Owner earnings: -604923.0769230769
Return on net tangible assets (%): -2.7256342714543185
Capex to operating income (%): 54.04308460817984
Buffett classification: The Good
Stock price: 8.35
Shares outstanding: 73705907
Book value: 70007076.92307693
P/B ratio: 8.79117298564321
Market cap (USD): 615444323.4499999
Debt to equity: 0.16357467157166528
Current ratio: 1.3850347089135895
Quick ratio: 1.3108943874243477
Effective tax rate (%): 301.13027959547884
Interest coverage ratio: 110.44827586206895
COGS to revenue (%): 27.4891302189839
R&D to revenue (%): 31.179892394131308
SG&A to revenue (%): 37.873493617105765
Free cash flow (dilution-adjusted): 5445538.461538462
Buyback yield (%): 0.06339384917335143
Retained earnings: -49550769.23076923
Inventory turnover: 1.7674240490171047
Receivables turnover: 0.8024055119678203
Capitalized R&D asset: 18106748.74955049
ROCI (R&D-adjusted, %): 1.675924395621497
Rosenberg metric: 0.212512069024549
FCF margin (%): 17.56834560940261
Revenue growth (%): 7.439541394480735
Rule of 40 score: 25.007887003883344
Financial ratios for CGNT — quarterly report dated 2026-01-31
Total revenue: 34382524.27184466
Gross profit: 25484789.644012947
Operating income: 1669902.9126213593
Net income: 1656310.6796116505
Capital expenditures: 712621.359223301
Operating cash flow: 6462135.922330097
Depreciation & amortization: 973786.4077669904
Net tangible assets: 22707119.741100326
Owner earnings: 1917475.7281553396
Return on net tangible assets (%): 8.444381101688874
Capex to operating income (%): 42.674418604651166
Buffett classification: The Good
Stock price: 9.03
P/E ratio: 454.58777085756907
Shares outstanding: 73705907
Book value: 74065695.79288027
P/B ratio: 8.98613498577271
Market cap (USD): 665564340.2099999
Debt to equity: 0.18805573640125314
Current ratio: 1.331302473185951
Quick ratio: 1.2580397512977421
Effective tax rate (%): -28.142213319979962
Interest coverage ratio: 101.1764705882353
COGS to revenue (%): 25.87865439280134
R&D to revenue (%): 30.704429509986632
SG&A to revenue (%): 38.46972007304079
Free cash flow (dilution-adjusted): 3991262.1359223304
Buyback yield (%): 0.265438900483948
Retained earnings: -50900000
Inventory turnover: 1.675033507980992
Receivables turnover: 0.8079915430188077
Capitalized R&D asset: 19883821.24241206
ROCI (R&D-adjusted, %): 2.2463682064063732
Rosenberg metric: 0.31135200073359043
FCF margin (%): 11.608403456260236
Revenue growth (%): 10.924580479556031
Rule of 40 score: 22.53298393581627
Financial ratios for CGNT — annual report dated 2026-01-31
Total revenue: 129463106.79611652
Gross profit: 93754368.93203884
Operating income: 4291585.760517799
Net income: 1492880.2588996764
Capital expenditures: 3364401.294498382
Operating cash flow: 13052103.55987055
Depreciation & amortization: 3876051.779935275
Net tangible assets: 22707119.741100326
Owner earnings: 2004530.7443365697
Return on net tangible assets (%): 8.827763129765552
Capex to operating income (%): 78.39529447251338
Buffett classification: The Gruesome
Stock price: 9.03
P/E ratio: 445.82566903292866
Shares outstanding: 73705907
Book value: 74065695.79288027
P/B ratio: 8.98613498577271
Market cap (USD): 665564340.2099999
Debt to equity: 0.18805573640125314
Current ratio: 1.331302473185951
Quick ratio: 1.2580397512977421
Effective tax rate (%): 59.32816081819785
Interest coverage ratio: 68.35567010309278
COGS to revenue (%): 27.582172827285202
R&D to revenue (%): 30.58086546129022
SG&A to revenue (%): 38.40881309665759
Free cash flow (dilution-adjusted): 2732686.0841423944
Buyback yield (%): 1.0423059664359609
Retained earnings: -50900000
Inventory turnover: 6.722310222980383
Receivables turnover: 3.0423913787465113
Capitalized R&D asset: 69527565.72077829
ROCI (R&D-adjusted, %): 6.539874859546808
Rosenberg metric: 0.8193900731172677
FCF margin (%): 2.11078364467642
Revenue growth (%): 32.183577748208144
Rule of 40 score: 34.29436139288456
Financial ratios for CHMI — annual report dated 2021-12-31
Capital expenditures: 55375000
Buffett classification: The Gruesome
Stock price: 3.9
Shares outstanding: 36739538
Market cap (USD): 143284198.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHMI — annual report dated 2022-12-31
Total revenue: 40193000
Net income: 22189000
Capital expenditures: 38036000
Operating cash flow: 59913000
Net tangible assets: 262035000
Owner earnings: -15847000
Return on net tangible assets (%): -6.047665388211499
Buffett classification: The Gruesome
Stock price: 3.23
P/E ratio: 5.348087238721889
Shares outstanding: 36739538
Book value: 265516000
P/B ratio: 0.446936183657482
Market cap (USD): 118668707.74
Debt to equity: 0.6925684327874779
Effective tax rate (%): 18.599361678711617
COGS to revenue (%): 0
SG&A to revenue (%): 32.17973278929166
Free cash flow (dilution-adjusted): 21877000
Buyback yield (%): 0
Retained earnings: -168989000
Receivables turnover: 0.7185918867216133
Capitalized R&D asset: 0
FCF margin (%): 54.42987584902844
Rule of 40 score: 54.42987584902844
Financial ratios for CHMI — annual report dated 2023-12-31
Total revenue: -21202000
Net income: -34794000
Capital expenditures: 0
Operating cash flow: 40659000
Net tangible assets: 255476000
Owner earnings: -34794000
Return on net tangible assets (%): -13.619283220341638
Buffett classification: The Gruesome
Stock price: 2.62
Shares outstanding: 36739538
Book value: 258375000
P/B ratio: 0.37254993540396714
Market cap (USD): 96257589.56
Debt to equity: 0.6553033381712627
Free cash flow (dilution-adjusted): 40659000
Buyback yield (%): 0
Retained earnings: -233161000
Receivables turnover: -2.675331230283912
Capitalized R&D asset: 0
Revenue growth (%): -152.75047893911875
Rule of 40 score: -152.75047893911875
Financial ratios for CHMI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.66
Shares outstanding: 36739538
Market cap (USD): 97727171.08
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHMI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.04
Shares outstanding: 36739538
Market cap (USD): 74948657.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHMI — annual report dated 2024-12-31
Total revenue: 34575000
Net income: 12210000
Capital expenditures: 0
Operating cash flow: -4691000
Net tangible assets: 230342000
Owner earnings: 12210000
Return on net tangible assets (%): 5.300813572861224
Buffett classification: The Gruesome
Stock price: 2.04
P/E ratio: 6.138301189189189
Shares outstanding: 36739538
Book value: 233622000
P/B ratio: 0.3208116423966921
Market cap (USD): 74948657.52
Debt to equity: 0.6473106128703633
Effective tax rate (%): 25.147130946542422
COGS to revenue (%): 0
SG&A to revenue (%): 52.82140274765004
Free cash flow (dilution-adjusted): -4691000
Buyback yield (%): 12.592620484871897
Retained earnings: -249643000
Receivables turnover: 3.612097785206853
Capitalized R&D asset: 0
FCF margin (%): -13.567606652205349
Rule of 40 score: -13.567606652205349
Financial ratios for CHMI — quarterly report dated 2025-03-31
Total revenue: -3050000
Net income: -6859000
Capital expenditures: 0
Operating cash flow: 682000
Net tangible assets: 226576000
Owner earnings: -6859000
Return on net tangible assets (%): -3.0272403078878614
Buffett classification: The Gruesome
Stock price: 2.67
Shares outstanding: 36739538
Book value: 229632000
P/B ratio: 0.42718160561245816
Market cap (USD): 98094566.46
Debt to equity: 0.650188127090301
Free cash flow (dilution-adjusted): 682000
Buyback yield (%): 0
Retained earnings: -263875000
Receivables turnover: -0.3042697525937749
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHMI — quarterly report dated 2025-06-30
Total revenue: 6037000
Net income: 1561000
Capital expenditures: 0
Operating cash flow: 12451000
Net tangible assets: 229892000
Owner earnings: 1561000
Return on net tangible assets (%): 0.6790144937622884
Buffett classification: The Gruesome
Stock price: 2.32
P/E ratio: 13.65082129404228
Shares outstanding: 36739538
Book value: 232413000
P/B ratio: 0.3667425150916687
Market cap (USD): 85235728.16
Debt to equity: 0.6427394336805601
Effective tax rate (%): 41.79716629381059
COGS to revenue (%): 0
SG&A to revenue (%): 55.57396057644526
Free cash flow (dilution-adjusted): 12451000
Buyback yield (%): 0
Retained earnings: -270241000
Receivables turnover: 0.41914878844685133
Capitalized R&D asset: 0
FCF margin (%): 206.2448235878748
Rule of 40 score: 206.2448235878748